BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 30105420)

  • 1. Role of Exosomes as a Treatment and Potential Biomarker for Stroke.
    Otero-Ortega L; Laso-García F; Gómez-de Frutos M; Fuentes B; Diekhorst L; Díez-Tejedor E; Gutiérrez-Fernández M
    Transl Stroke Res; 2019 Jun; 10(3):241-249. PubMed ID: 30105420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Exosomes for the Treatment of Stroke.
    Hong SB; Yang H; Manaenko A; Lu J; Mei Q; Hu Q
    Cell Transplant; 2019 Jun; 28(6):662-670. PubMed ID: 30520322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Release of Exosomes From Astrocytes Contributes to the Increase in Neural Plasticity and Improvement of Functional Recovery After Stroke in Rats Treated With Exosomes Harvested From MicroRNA 133b-Overexpressing Multipotent Mesenchymal Stromal Cells.
    Xin H; Wang F; Li Y; Lu QE; Cheung WL; Zhang Y; Zhang ZG; Chopp M
    Cell Transplant; 2017 Feb; 26(2):243-257. PubMed ID: 27677799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy.
    Chang YH; Wu KC; Harn HJ; Lin SZ; Ding DC
    Cell Transplant; 2018 Mar; 27(3):349-363. PubMed ID: 29692195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes.
    Guy R; Offen D
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes Treatment Mitigates Ischemic Brain Damage but Does Not Improve Post-Stroke Neurological Outcome.
    Nalamolu KR; Venkatesh I; Mohandass A; Klopfenstein JD; Pinson DM; Wang DZ; Veeravalli KK
    Cell Physiol Biochem; 2019; 52(6):1280-1291. PubMed ID: 31026391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke.
    Chen KH; Chen CH; Wallace CG; Yuen CM; Kao GS; Chen YL; Shao PL; Chen YL; Chai HT; Lin KC; Liu CF; Chang HW; Lee MS; Yip HK
    Oncotarget; 2016 Nov; 7(46):74537-74556. PubMed ID: 27793019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles.
    Dabrowska S; Andrzejewska A; Lukomska B; Janowski M
    J Neuroinflammation; 2019 Sep; 16(1):178. PubMed ID: 31514749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes derived from mesenchymal stem cells.
    Yu B; Zhang X; Li X
    Int J Mol Sci; 2014 Mar; 15(3):4142-57. PubMed ID: 24608926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke.
    Rahmani A; Saleki K; Javanmehr N; Khodaparast J; Saadat P; Nouri HR
    Ageing Res Rev; 2020 Sep; 62():101106. PubMed ID: 32565329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
    Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C
    Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and Therapeutic Uses of Exosomes: A New Potential Tool in Orthopedics.
    Vitha AE; Kollefrath AW; Huang CC; Garcia-Godoy F
    Stem Cells Dev; 2019 Jan; 28(2):141-150. PubMed ID: 30426846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke.
    Doeppner TR; Bähr M; Hermann DM; Giebel B
    Stem Cells Transl Med; 2017 Nov; 6(11):2044-2052. PubMed ID: 28941317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of exosomes in stroke.
    Wang MM; Feng YS; Tan ZX; Xing Y; Dong F; Zhang F
    Mol Biol Rep; 2020 Aug; 47(8):6217-6228. PubMed ID: 32514999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous xenogeneic human cardiosphere-derived cell extracellular vesicles (exosomes) improves behavioral function in small-clot embolized rabbits.
    Lapchak PA; Boitano PD; de Couto G; Marbán E
    Exp Neurol; 2018 Sep; 307():109-117. PubMed ID: 29908146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke.
    Bedini G; Bersano A; Zanier ER; Pischiutta F; Parati EA
    Curr Med Chem; 2018; 25(19):2176-2197. PubMed ID: 29332564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery.
    Ueno Y; Hira K; Miyamoto N; Kijima C; Inaba T; Hattori N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases.
    Gorabi AM; Kiaie N; Barreto GE; Read MI; Tafti HA; Sahebkar A
    Mol Neurobiol; 2019 Dec; 56(12):8157-8167. PubMed ID: 31197655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.